Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder

The acute treatment duration for major depressive disorder (MDD) is 8 weeks or more. Treatment of patients with MDD without predictors of treatment response and future recurrence presents challenges and clinical problems to patients and physicians. Recently, many neuroimaging studies have been publi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Seung-Gul, Cho, Seo-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139562/
https://www.ncbi.nlm.nih.gov/pubmed/32245086
http://dx.doi.org/10.3390/ijms21062148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139562/
https://www.ncbi.nlm.nih.gov/pubmed/32245086
http://dx.doi.org/10.3390/ijms21062148

Ejemplares similares